Abstract
Prostacyclin (PGI2) is a powerful inhibitor of platelet aggregation, but its role in the pathogenesis of arterial thrombosis is uncertain. We have studied the thrombogenic effect of inhibiting PGI2 production by aspirin (ASA) in carotid arteries of rabbits given 0, 3, 10, or 100 mg ASA/kg either 1, 3, 6, or 20 h beforehand. Platelet accumulation onto injured carotid arteries was enhanced with ASA in a dose of 10 mg/kg. A higher dose of ASA (100 mg/kg) had no further effect. The enhanced thrombogenic effect of ASA persisted for at least 20 h and was associated with a decrease in vessel wall PGI2 production. There was a strong inverse correlation (r = 0.55, P less than 0.01) between PGI2 production and platelet accumulation. The findings suggest that the margin of safety in obtaining an antithrombotic effect of ASA and producing a potential thrombotic effect in arteries may not be as large as predicted by studies using cultured endothelial cells or experimentally induced thrombosis in veins.
Full text
PDF





Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Baenziger N. L., Dillender M. J., Majerus P. W. Cultured human skin fibroblasts and arterial cells produce a labile platelet-inhibitory prostaglandin. Biochem Biophys Res Commun. 1977 Sep 9;78(1):294–301. doi: 10.1016/0006-291x(77)91253-0. [DOI] [PubMed] [Google Scholar]
- Buchanan M. R., Blajchman M. A., Dejana E., Mustard J. F., Senyi A. F., Hirsh J. Shortening of the bleeding time in thrombocytopenic rabbits after exposure of jugular vein to high aspirin concentration. Prostaglandins Med. 1979 Dec;3(6):333–342. doi: 10.1016/0161-4630(79)90026-0. [DOI] [PubMed] [Google Scholar]
- Buchanan M. R., Dejana E., Cazenave J. P., Mustard J. F., Hirsh J. Uncontrolled PGI2 production by whole vessel wall segments due to thrombin generation in vivo and its prevention by heparin. Thromb Res. 1979;16(3-4):551–555. doi: 10.1016/0049-3848(79)90102-6. [DOI] [PubMed] [Google Scholar]
- Cazenave J. P., Dejana E., Kinlough-Rathbone R., Packham M. A., Mustard J. F. Platelet interactions with the endothelium and the subendothelium: the role of thrombin and prostacyclin. Haemostasis. 1979;8(3-5):183–192. doi: 10.1159/000214310. [DOI] [PubMed] [Google Scholar]
- Curwen K. D., Gimbrone M. A., Jr, Handin R. I. In vitro studies of thromboresistance: the role of prostacyclin (PGI2) in platelet adhesion to cultured normal and virally transformed human vascular endothelial cells. Lab Invest. 1980 Mar;42(3):366–374. [PubMed] [Google Scholar]
- Czervionke R. L., Hoak J. C., Fry G. L. Effect of aspirin on thrombin-induced adherence of platelets to cultured cells from the blood vessel wall. J Clin Invest. 1978 Oct;62(4):847–856. doi: 10.1172/JCI109197. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Czervionke R. L., Smith J. B., Hoak J. C., Fry G. L., Haycraft D. L. Use of a radioimmunoassay to study thrombin-induced release of PGI2 from cultured endothelium. Thromb Res. 1979;14(4-5):781–786. doi: 10.1016/0049-3848(79)90132-4. [DOI] [PubMed] [Google Scholar]
- Dejana E., Cazenave J. P., Groves H. M., Kinlough-Rathbone R. L., Richardson M., Packham M. A., Mustard J. F. The effect of aspirin inhibition of PGI2 production on platelet adherence to normal and damaged rabbit aortae. Thromb Res. 1980 Feb 1;17(3-4):453–464. doi: 10.1016/0049-3848(80)90080-8. [DOI] [PubMed] [Google Scholar]
- Fields W. S., Lemak N. A., Frankowski R. F., Hardy R. J. Controlled trial of aspirin in cerebral ischemia. Stroke. 1977 May-Jun;8(3):301–314. doi: 10.1161/01.str.8.3.301. [DOI] [PubMed] [Google Scholar]
- Gryglewski R. J., Bunting S., Moncada S., Flower R. J., Vane J. R. Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides. Prostaglandins. 1976 Nov;12(5):685–713. doi: 10.1016/0090-6980(76)90047-2. [DOI] [PubMed] [Google Scholar]
- Harris W. H., Salzman E. W., Athanasoulis C. A., Waltman A. C., DeSanctis R. W. Aspirin prophylaxis of venous thromboembolism after total hip replacement. N Engl J Med. 1977 Dec 8;297(23):1246–1249. doi: 10.1056/NEJM197712082972302. [DOI] [PubMed] [Google Scholar]
- Harter H. R., Burch J. W., Majerus P. W., Stanford N., Delmez J. A., Anderson C. B., Weerts C. A. Prevention of thrombosis in patients on hemodialysis by low-dose aspirin. N Engl J Med. 1979 Sep 13;301(11):577–579. doi: 10.1056/NEJM197909133011103. [DOI] [PubMed] [Google Scholar]
- Jaffe E. A., Weksler B. B. Recovery of endothelial cell prostacyclin production after inhibition by low doses of aspirin. J Clin Invest. 1979 Mar;63(3):532–535. doi: 10.1172/JCI109332. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kelton J. G., Hirsh J., Carter C. J., Buchanan M. R. Thrombogenic effect of high-dose aspirin in rabbits. Relationship to inhibition of vessel wall synthesis of prostaglandin I2-like activity. J Clin Invest. 1978 Oct;62(4):892–895. doi: 10.1172/JCI109203. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Marcus A. J. Aspirin and thromboembolism--a possible dilemma. N Engl J Med. 1977 Dec 8;297(23):1284–1285. doi: 10.1056/NEJM197712082972312. [DOI] [PubMed] [Google Scholar]
- Marcus A. J. The role of lipids in platelet function: with particular reference to the arachidonic acid pathway. J Lipid Res. 1978 Sep;19(7):793–826. [PubMed] [Google Scholar]
- O'Grady J., Moncada S. Aspirin: A paradoxical effect on bleeding-time. Lancet. 1978 Oct 7;2(8093):780–780. doi: 10.1016/s0140-6736(78)92661-2. [DOI] [PubMed] [Google Scholar]
- Roth G. J., Majerus P. W. The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein. J Clin Invest. 1975 Sep;56(3):624–632. doi: 10.1172/JCI108132. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weksler B. B., Ley C. W., Jaffe E. A. Stimulation of endothelial cell prostacyclin production by thrombin, trypsin, and the ionophore A 23187. J Clin Invest. 1978 Nov;62(5):923–930. doi: 10.1172/JCI109220. [DOI] [PMC free article] [PubMed] [Google Scholar]

